Medial EarlySign’s technology is built on the premise that the best way to treat a disease is to identify it before onset, or at very early stages. The company’s big data platform integrates the latest machine learning technology and leading clinical science to create a powerful prediction engine.
Medial EarlySign has built and refined a unique algorithmic platform designed to handle large medical data and billions of medical data elements. Our platform works at processing speeds up to x1000 faster than conventional off-the-shelf tools. This unique approach allows Medial EarlySign to swiftly process large amounts of data in very short cycles and craft models that predict clinical outcomes with a high degree of confidence and a low risk of over fitting. Our state-of-the-art machine learning toolset was designed to handle large-scale medical databases with industry-leading efficiency, and our proprietary data-store was expressly built for medical data analytics.
Further models, targeting various medical conditions or treatments and utilizing new data and outcomes can be developed with high precision and speed. Our custom solutions can deliver data-driven patient-level predictions that lead to targeted, cost-effective management of populations and sub-populations at risk. Using our partners’ data and our know-how, we can leverage our expertise and allow you to build and tailor solutions that indicate sub populations with elevated risk for severe outcomes
Our solution is tailor-made for your organization and is implemented by the following three steps
Our solutions provide clients with cost effective, non-invasive tools for personalized, accurate and proactive medicine. By reaching those in need earlier, we help our partners to save lives and costly resources.